Sedana Medical Q4: Slightly better than expected

Research Update

2023-02-17

07:30

Redeye returns with a more in-depth take on Sedana Medical’s Q4 report. We leave our financial estimates for the coming years untouched but argue that the report further underpins our favourable stance on the company’s outlook.

OB

Oscar Bergman

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.